By Scientia Professor Louisa Jane Degenhardt

Conference Abstracts

Jacka B; Larney S; Hoj S; Degenhardt L; Krajden M; Janjua N; Grebely J; Bruneau J, 2018, 'Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 131 - 131, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trickey A; Fraser H; Lim AG; Walker J; Peacock A; Colledge S; Leung J; Grebely J; Larney S; Degenhardt L; Hickman M; May M; Vickerman P, 2018, 'Comparing the prevention gains of different treatment strategies at the global, regional, and country level: a modelling study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, Vol. 68, pp. S179 - S180, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461068600354&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trickey A; Fraser H; Lim AG; Walker J; Peacock A; Colledge S; Leung J; Grebely J; Larney S; Degenhardt L; Hickman M; Vickerman P, 2018, 'The contribution of injecting drug use to Hepatitis C virus transmission globally, regionally, and at country level: a modelling study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, Vol. 68, pp. S179 - S179, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461068600353&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Roxburgh A; Sutherland R; Uporova J; Karlsson A; Gibbs D; Degenhardt L; Bruno R; Dietze PM; Lenton S; Alati R; Farrell M, 2018, 'AVAILABILITY AND USE OF NEW AND EMERGING PSYCHOACTIVE SUBSTANCES IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S57 - S58

Prestage GP; Hammoud MA; Maher L; Degenhardt L; Bourne A; Lea T; Mackie B; Bath N; Haire BG; Batrouney C; Jin F, 2018, 'INITIATION OF ILLICIT DRUG USE IN THE FLUX COHORT OF AUSTRALIAN GAY AND BISEXUAL MEN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S60 - S60

Peacock A; Bruno R; Roxburgh A; Mathur A; Dietze PM; Lenton S; Alati R; Gisev N; Memedovic S; Crossin R; Scott D; Lubman DI; Smith K; Brown J; Cairns R; Jauncey M; Sutherland R; Gibbs D; Uporova J; Karlsson A; Degenhardt L; Farrell M, 2018, 'TRENDS IN FENTANYL AVAILABILITY, USE AND HARMS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S56 - S56

Campbell G; Nielsen S; Lintzeris N; Bruno R; Peacock A; Chan GCK; Larance B; Cohen M; Farrell M; Hall WD; Degenhardt L, 2017, 'CANNABIS USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: OBSERVATIONS FROM THE POINT COHORT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 24 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Larance B; Lintzeris N; Holliday S; Dunlop AJ; Haber PS; Murnion BP; Silsbury C; Johnson J; Demirkol A; Ling S; Sadler C; Phung N; Bruno R; Hardy M; Brown AL; Houseman J; Degenhardt L, 2017, 'TREATING OVER THE COUNTER CODEINE DEPENDENCE: TWO YEAR OUTCOMES FROM A COHORT OF PHARMACEUTICAL OPIOID DEPENDENT PEOPLE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 13 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'DEFINING PROBLEMATIC PHARMACEUTICAL OPIOID USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: DO DIFFERENT MEASURES IDENTIFY THE SAME PATIENTS?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larney S; Grebely J; Degenhardt L; Amin J; Law M; Alavi M; Dore GJ; Law M, 2016, 'EXPOSURE TO OPIOID SUBSTITUTION THERAPY FOLLOWING HEPATITIS C NOTIFICATION: IMPLICATIONS FOR PROVISION OF ANTIVIRAL THERAPIES IN DRUG TREATMENT SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 48 - 48

Moore T; O'Donnell C; Degenhardt L; Campbell G; Nielsen S; Larance B, 2016, 'PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 55 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Ali R; Farrell M; Peacock A; Bruno R; Lintzeris N; Dobbins T; Degenhardt L, 2016, 'THE IMPACT OF REFORMULATED OXYCONTIN (R) IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lea T; Hammoud MA; Jin F; Degenhardt L; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Maher L; Prestage GP, 2016, 'ATTITUDES TOWARDS ILLICIT DRUG USE AMONG GAY AND BISEXUAL MEN IN AUSTRALIA: EVIDENCE FOR NORMALISATION?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 49 - 49

Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2016, 'OVERDOSE KNOWLEDGE AND PERCEPTIONS OF TAKE-HOME NALOXONE FOR PATIENTS WITH CHRONIC NON-CANCER PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 56 - 57

Prestage GP; Jin F; Hammoud MA; Degenhardt L; Lea T; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Maher L, 2016, 'PARTY DRUG USE WITHIN GAY COMMUNITY NETWORKS IN AN ONLINE COHORT OF GAY AND BISEXUAL MEN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 62 - 62

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Peacock A; Chrzanowska A; Degenhardt L; Miller M; Yuen WS; Clare P; Tisdale C; Yuen WS, 2024, Prospective longitudinal cohorts of young Australians and their assessment of alcohol-related measures, National Drug and Alcohol Research Centre, Sydney, http://dx.doi.org/10.26190/unsworks/30604

Sutherland R; Chandrasena U; Karlsson A; Uporova J; Tayeb H; Price O; Salom C; Bruno R; Dietze P; Lenton S; Daly C; Thomas N; Radke S; Lloyd Z; Grigg J; Haywood S; Degenhardt L; Farrell M; Peacock A; Haywood S, 2024, Australian Drug Trends 2024: Key Findings From the National Ecstasy and Related Drugs Reporting System (EDRS) Interview, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30462, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-edrs

Sutherland R; Karlsson A; Uporova J; Chandrasena U; Tayeb H; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Vella-Horne D; Haywood S; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Salom C; Radke S; Farrell M, 2024, Australian Drug Trends 2024: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30464, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-idrs

Sutherland R; Chandrasena U; Karlsson A; Uporova J; Tayeb H; Price O; Salom C; Bruno R; Dietze P; Lenton S; Daly C; Thomas N; Radke S; Lloyd Z; Grigg J; Haywood S; Degenhardt L; Farrell M; Peacock A, 2024, Ecstasy And Related Drugs Reporting System (EDRS) Interviews 2024: Background And Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30463, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-edrs

Sutherland R; Karlsson A; Uporova J; Chandrasena U; Tayeb H; Price O; Bruno R; Dietze P; Lenton S; Salom C; Radke S; Vella-Horne D; Haywood S; Daly C; Thomas N; Degenhardt L; Farrell M; Peacock A; Tayeb H, 2024, Illicit Drug Reporting System (IDRS) Interviews 2024: Background and Methods, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30465, https://www.unsw.edu.au/research/ndarc/resources/australian-drug-trends-2024-key-findings-from-the-idrs

Chrzanowska A; Man N; Akhurst J; Sutherland R; Degenhardt L; Peacock A; Peacock A, 2024, Methods for trends in drug-related hospitalisations in Australia, 2002-2022, National Drug and Alcohol Reseach Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/30518, https://www.unsw.edu.au/research/ndarc/resources/trends-drug-related-hospitalisations-australia-2002-2022

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2024, Trends in drug-related hospitalisations in Australia, 2002-2022, NDARC, Sydney, http://dx.doi.org/10.26190/unsworks/30193, https://www.unsw.edu.au/research/ndarc/resources/trends-drug-related-hospitalisations-australia-2002-2022

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2024, Trends in overdose and other drug-induced deaths in Australia, 2003-2022, NDARC, Sydney, http://dx.doi.org/10.26190/unsworks/30158

Asare-Doku W; Stolk S; Peacock AMY; Shakeshaft A; Waller E; Nathan S; Economidis G; Ravulo J; Meo-Sewabu L; D'Este C; Thapa P; Abbott T; Satour T; Tulele L; Wilson K; Doran C; Mhey-Rivas T; Macpherson G; Lynch M; Taylor S; Santo T; Graham D; Baillie G; Tran A; Aiken A; Harwood E; Turner A; Reeve R; Degenhardt L; Farrell M, 2023, Monitoring and Evaluation of the Kava Pilot Program, National Drug and Alcohol Research Centre, UNSW, Sydney, https://www.odc.gov.au/resources/publications/monitoring-and-evaluation-kava-pilot-program

Sutherland R; Karlsson A; King C; Uporova J; Chandrasena U; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Grigg J; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1qta-pe36, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-ecstasy-and-related-drugs-reporting

Sutherland R; Uporova J; King C; Chandrasena U; Karlsson A; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Agramunt S; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1tj1-8454, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-illicit-drug-reporting-system-idrs

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Yuen WS; Walsberger S; Sutherland R; Price K; Degenhardt L; Reakes K; Cerio R; Woolley N; King C; Spencer E; Vaughan M; Watson L; Miller N; Clay S; Symes E; Peacock A, 2023, Alcohol-related behaviours, beliefs, and knowledge regarding cancer risk related to alcohol in the New South Wales LGBTQ+ community, National Drug and Alcohol Research Centre, Sydney, 354, http://dx.doi.org/10.26190/5mty-d787, https://ndarc.med.unsw.edu.au/resource/alcohol-related-behaviours-beliefs-and-knowledge-regarding-cancer-risk-related-alcohol-new

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chrzanowska A; Man N; Akhurst J; Sutherland R; Degenhardt L; Peacock A, 2023, Trends in Overdose and Other Drug-Induced Deaths in Australia, 2002-2021, NDARC, Sydney, http://dx.doi.org/10.26190/m2gs-z325, https://ndarc.med.unsw.edu.au/resource-analytics/trends-drug-induced-deaths-australia-2002-2021

Asare-Doku W; Macdonald C; Ottaviano S; Degenhardt L; Farrell M, 2023, Review of interventions to treat drug use disorders among girls and women in the criminal justice system in low- and middle-income countries, https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_66/ECN72023_CRP10_2304065E.pdf

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Clay S; Yuen WS; Spencer E; Peacock A; Walsberger S; Price K; Sutherland R; Degenhardt L; Popovski H, 2023, Perceptions of risky alcohol use, health risks related to alcohol, and alcohol-related help-seeking in the LGBTQ+ community, https://ndarc.med.unsw.edu.au/project/perceptions-risky-alcohol-use-health-risks-related-alcohol-and-alcohol-related-help-seeking

Brothers T; Degenhardt L, 2022, Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018, UCL Press, http://dx.doi.org/10.14324/000.rp.10157481, http://dx.doi.org/10.14324/000.rp.10157481

Chrzanowska A; Man N; Akhurst J; Sutherland R; Degenhardt L; Peacock A, 2022, Trends in drug-related hospitalisations in Australia, 1999-2021., NDARC, Sydney, http://dx.doi.org/10.26190/wrsv-3b78

Sutherland R; Karlsson A; King C; Jones F; Uporova J; Price O; Gibbs D; Bruno R; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Wilson J; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2022, Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/hbqt-9d09

Sutherland R; Karlsson A; King C; Jones F; Uporova J; Price O; Gibbs D; Bruno R; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Wilson J; Daly C; Thomas N; Juckel J; Agramunt S; Que Noy W; Degenhardt L; Farrell M; Peacock A, 2022, Australian Drug Trends 2022: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/5czp-af24

Man N; Sisson S; McKetin R; Chrzanowska A; Bruno R; Dietze P; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, Trends in methamphetamine use, markets and harms in Australia, 2003-2019, NDARC, Sydney, http://dx.doi.org/10.26190/ad59-k695

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2022, Trends in overdose and other drug-induced deaths in Australia, 1997-2020, NDARC, Sydney, http://dx.doi.org/10.26190/ke9y-4731

Chrzanowska A; Man N; Sutherland R; Degenhardt L; Peacock A, 2021, Trends in drug-related hospitalisations in Australia, 1999-2020, NDARC, Sydney, http://dx.doi.org/10.26190/xzey-zb70

Back to profile page